Acute coronary syndrome
270 results
201 - 270
Exercise stress test - Antithrombotic agents in primary health care
Niacin not effective in CAD with low HDL cholesterol (AIM-HIGH)- Similar number of cardiovascular events and reduced bleeding with abbreviated dual antiplatelet therapy after PCI
- In patients with vascular disease, treating sleep apnea does not reduce the risk of cardiovascular events
- Lipid lowering is beneficial for secondary prevention but not primary prevention in patients 75 years and older
Dialysate temperature reduction for intradialytic hypotension for people with chronic kidney disease requiring haemodialysis- Interpretation of adult ECG
- COVID-19 and other coronavirus infections
- Clarithromycin associated with cardiovascular events
- Increased readmissions and adverse events with intensification of antihypertensive regimen on hospital discharge
- Promoting patient utilisation of cardiac rehabilitation
- Small reduction in CV outcome after ischemic stroke with lower LDL target, but also harms; no change in all-cause mortality
- Hyperbaric oxygen therapy (HBOT)
- No reduction in postdischarge medication errors after pharmacist-led intervention
- Antiplatelet agents for chronic kidney disease
- Acute abdomen in the adult
- Acute heart failure and pulmonary oedema
- AABB recommends restrictive transfusion strategy for hospitalized patients
- Ipratropium associated with increase risk of CV events
- Taking furosemide on day of surgery does not increase intraop hypotension
- SBP of 120 instead of 140 in adults 75 years or older = significant benefits and some harms (SPRINT)
- Mortality rate in patients with recent ACS and endoscopy is similar to that in patients with ACS and no endoscopy
- Interpreting BNP in patients with a history of HF
- SBP of 120 instead of 140 in nondiabetic, high-risk elderly leads to significant benefits and some harms (SPRINT)
- Single nondetectable high-sensitivity troponin result rules out AMI
- Sotagliflozin reduces hospitalizations and urgent visits in patients with T2DM and recent HF hospitalization (SOLOIST-WHF)
- Restrictive transfusion strategies are appropriate for most critically ill patients with varying levels of evidence
- Syncope: causes and investigations
- Clinical decision rules for evaluating adults with chest pain in primary care are limited in number and utility — stay tuned
- Increased postoperative 30-day mortality within 1 year of a cardiovascular event
- Viral hepatitis
- Bariatric surgery is associated with fewer major adverse cardiac events than GLP-1 agonists in obese adults with type 2 diabetes
- Legislative smoking bans for reducing secondhand smoke exposure and smoking prevalence
- Management of acute atrial fibrillation
- Final report from SPRINT: lowering SBP below 120 mm Hg decreases major adverse cardiac events and all-cause mortality
- Indications for and implementation of anticoagulant therapy in atrial fibrillation
- Chronic heart failure
- Risk of stroke after TIA is 2.8% at 1 month and 5.1% at 1 year
- Cardiac biomarkers (BNP and troponin) useful for diagnosis and prognosis of cardiac syncope (BASEL IX)
- Warfarin therapy
- In high-risk older patients with atrial fibrillation, rhythm control reduces cardiovascular death and stroke, but at a price
- Higher blood pressure targets for hypertension in older adults
- Treatment of dyslipidaemias
- Angiotensin II increases BP in vasodilatory shock resistant to high-dose vasopressors
- Apixaban reduces stroke and embolism more than aspirin in A fib
- Identification of illegal drug overdose and diagnosis of illegal drug poisoning
- Ezetimibe for the prevention of cardiovascular disease and all‐cause mortality events
- Overview of new ACC/AHA lipid guidelines: here we go again
- Comprehensive treatment and follow-up of type 2 diabetes
- Heart valve operation: patient follow-up and complications
- For atrial fibrillation with ACS or PCI, apixaban plus clopidogrel (without aspirin) is preferred (AUGUSTUS)
- Legislative smoking bans for reducing harms from secondhand smoke exposure, smoking prevalence and tobacco consumption: Cochrane systematic review
- Behavioural activation therapy for depression in adults with non‐communicable diseases
- Mobile phone text messaging for medication adherence in secondary prevention of cardiovascular disease
- Supraventricular tachycardia (SVT)
- Prehospital emergency care
- Transfusion thresholds for guiding red blood cell transfusion
- Atherectomy for peripheral arterial disease
- Replacing salt with low‐sodium salt substitutes (LSSS) for cardiovascular health in adults, children and pregnant women
- Oral antidiabetic drugs and GLP-1 analogues
- Prevention of depression in adults with long‐term physical conditions
- Palliative treatment